reglab/statecodes huggingface dataset:
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-8 - Drug testing

Current through Vol. 41, No. 20, July 1, 2024
(a) Each OTP shall
				  have written policy and procedure ensuring that an initial drug test is
				  performed for each new person served, including permanent transfers, before the
				  initial or maintenance dose is administered. All drug testing shall be in
				  accordance with all state and federal law and current drug screen standards.
				  Unless federal opioid treatment standards at
				  42 CFR §
											8.12 state otherwise, OTPs must provide drug
				  tests that have received FDA marketing authorization for commonly used and
				  misused substances that may impact safety, recovery, or otherwise complicate
				  treatment. A minimum of eight (8) random drug tests shall be performed each
				  year for each person served, with the exception of persons served with
				  extenuating circumstances which are documented in the clinical
				  record.
(b) Each OTP shall conduct
				  drug testing in accordance with the following:
(1) When a sample is collected from each
				  person served for such test or analysis, it must be done in a manner to produce
				  timely and reliable results.
(2)
				  The OTP must have and follow written procedures for the screening of test
				  samples for all drugs. The procedures shall describe in sufficient detail a
				  plan for collection, storage, handling and analysis of test samples. The
				  procedures shall further describe the program's response to test results that
				  include at least the following:
(A) training
				  for staff members of the importance and relevance of reliable and timely drug
				  abuse test procedures and reports, the purpose of conducting drug tests, and
				  the clinical significance of the results;
(B) A protocol for collection of test samples
				  that minimizes the opportunity for falsification and incorporates the element
				  of randomness;
(C) A protocol for
				  storage of test samples in a secure place to ensure chain of custody and avoid
				  substitution;
(D) A requirement for
				  disclosure of test sample results to the person served and documentation in the
				  clinical record of the response to the test results of the program and person
				  served;
(E) Policy and procedure
				  designed to reduce the negative and/or stigmatizing aspects of drug test
				  collection;
(F) Policy stating that
				  if a person served refuses to provide a test sample, upon request from a staff
				  member, such refusal shall be considered the same as a positive result for
				  illicit drugs. Such refusals shall be documented in the clinical record;
				  and
(G) There shall be no "grace
				  period" allowed. Persons served from which a UA is requested must submit a
				  sample at that time or it will be considered a refusal.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-8.1

Current through Vol. 41, No. 20, July 1, 2024
Added at 30 Ok Reg 1448, eff
						7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-8.2 - Drug testing - Required substance identification

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall have written policy and
				  procedure stating drug screens will follow federal guidelines and will, at a
				  minimum, test for the following substances;
(1) Opioids;
(2) Methadone;
(3) Amphetamines;
(4) Cocaine;
(5) Benzodiazepines; and
(6) Barbiturates.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-8.3 - Take-home doses, general criteria

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall
				  have written policy and procedure stating that unsupervised take-home use shall
				  be determined by the medical director. In determining which persons served may
				  be permitted unsupervised take-home use, the medical director shall consider
				  the following criteria in determining whether a person served is responsible in
				  handling opioid medications. The same criteria shall be considered when
				  receiving a person served from a transferring program verifying the amount of
				  time the person served has spent satisfactorily adhering to the criteria found
				  below. This information will be used to determine if the person served shall be
				  allowed to continue the same frequency of clinic attendance permitted at the
				  former program immediately before transferring to the new program. Criteria
				  include but are not limited to:
(1) Absence
				  of recent unapproved use of drugs (opioid or non-narcotic), including
				  alcohol;
(2) Regular clinic
				  attendance;
(3) Absence of serious
				  behavioral problems at the clinic;
(4) Absence of known recent criminal
				  activity, e.g., drug dealing;
(5)
				  Stability of the home environment and social relationships of the person
				  served;
(6) Length of time in
				  comprehensive maintenance treatment;
(7) Assurance that take-home medication can
				  be safely stored within the home of the person served;
(8) Whether the rehabilitative benefit the
				  person served derived from decreasing the frequency of clinic attendance
				  outweighs the potential risks of diversion; and
(9) The current phase in treatment of the
				  person served.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-8.4 - Take-home doses, general requirements

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall
				  have written policy and procedure describing practices in accordance with the
				  principle that take-home doses of methadone and buprenorphine are a privilege
				  given only to those persons served who will benefit from them and who have
				  demonstrated responsibility in taking methadone or buprenorphine as prescribed
				  including:
(1) Programs must educate the
				  person served regarding safe transportation and storage of methadone, as well
				  as emergency procedures in case of accidental ingestion.
(2) Before take-home privileges are allowed,
				  the person served must have a lock box for transportation of methadone and home
				  storage.
(3) The program shall
				  address the responsibilities of persons served granted take-home medications.
				  The policies shall include methods of assuring appropriate use and storage of
				  medication by persons served.
(4)
				  The program shall address the disposal of take-home bottles for methadone to
				  include;
(A) Requiring take-home bottles to
				  be returned to the OTP and to require labels to be intact and the consequences
				  for not returning bottles described.
(B) Allowing disposal of take-home bottles to
				  include procedures to insure the ability of the OTP to check for diversion by
				  requiring persons served to submit used take-home bottles in "call
				  backs."
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-8.5 - Take-home doses, limits

Current through Vol. 41, No. 20, July 1, 2024
(a) With the
				  exception of FDA-approved buprenorphine and buprenorphine combination products
				  for opioid use disorder, take-home doses shall be limited, in accordance with
				  42 CFR §
											8.12. Unless requirements at
				  42 CFR §
											8.12 state otherwise, take-home doses shall
				  be limited as follows:
(1) Any person served
				  in comprehensive treatment may receive their individualized take-home doses as
				  ordered for days the OTP is closed for business, including one weekend day and
				  State and Federal holidays, regardless of length of time in
				  treatment.
(2) During the first
				  fourteen (14) days of treatment, the take-home supply (beyond that of (1) in
				  this subsection) is limited to seven (7) days.
(3) Beginning at fifteen (15) days of
				  treatment, the take-home supply (beyond that of (1) in this subsection) is
				  limited to fourteen (14) days.
(4)
				  Beginning at thirty-one (31) days of treatment, the take-home supply (beyond
				  that of (1) in this subsection) is limited to twenty-eight (28)
				  days.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-9

Current through Vol. 41, No. 20, July 1, 2024
Added at 24 Ok Reg 2634, eff 7-12-07 ; Amended at 30 Ok
						Reg 1449, eff 7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-10

Current through Vol. 41, No. 20, July 1, 2024
Added at 24 Ok Reg 2634, eff 7-12-07 ; Amended at 30 Ok
						Reg 1449, eff 7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-11

Current through Vol. 41, No. 20, July 1, 2024
Added at 24 Ok Reg 2634, eff 7-12-07 ; Amended at 30 Ok
						Reg 1449, eff 7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 4 - Services Support and Enhancement › Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT › Section 450:70-4-12 - Community information, consultation, outreach, and street outreach [REVOKED]

Current through Vol. 41, No. 20, July 1, 2024
Added at 24 Ok Reg 2634, eff 7-12-07 ; Amended at 30 Ok
						Reg 1450, eff 7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 5 - Consumer Rights › Section 450:70-5-1 - Consumer rights

Current through Vol. 41, No. 20, July 1, 2024
(a) All OTPs shall
				comply with applicable rules in Title 450, Chapter 15. Consumer
				Rights.
(b) Compliance with 70-5-2
				may be determined by a review of the following:
(1) Policy and Procedures,
(2) Review of treatment records,
				and
(3) Any other supporting
				facility documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 5 - Consumer Rights › Section 450:70-5-2 - Consumer's grievance policy

Current through Vol. 41, No. 20, July 1, 2024
(a) Each
				treatment facility shall comply with applicable rules in Title 450, Chapter 15.
				Consumer Rights.
(b) Compliance
				with 70-5-2 may be determined by a review of the following:
(1) Policy and Procedures,
(2) Review of treatment records,
				and
(3) Any other supporting
				facility documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 5 - Consumer Rights › Section 450:70-5-3 - ODMHSAS advocate general

Current through Vol. 41, No. 20, July 1, 2024
(a) The ODMHSAS
				Advocate General, in any investigation regarding consumer rights, shall have
				access to consumers, facility records and facility staff as set forth in Title
				450, Chapter 15.
(b) Compliance
				with 70-5-3 may be determined by a review of the following:
(1) Policy and Procedures,
(2) Review of all facility records,
				and
(3) Investigations, site
				visits, treatment protocols, clinical records, clinical service manuals and
				certification reviews.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 1 - CASE MANAGEMENT › Section 450:70-6-1 - Case management services

Current through Vol. 41, No. 20, July 1, 2024
(a) Case management
				  services shall be provided in accordance with Chapter 50 of this Title and
				  shall include planned referral, linkage, monitoring and support, and advocacy
				  assistance provided in partnership with a person served to support that
				  individual in self-sufficiency and community tenure. Activities include:
(1) Completion of strengths based assessment
				  for the purpose of individual plan of care development;
(2) Development of case management care plan
				  which can be reflected as a part of the comprehensive service plan;
(3) Referral, linkage and advocacy to assist
				  with gaining access to appropriate community resources;
(4) Contacts with other individuals and
				  organizations that influence the recipient's relationship with the community,
				  i.e., family members, law enforcement personnel, landlords, etc.;
(5) Monitoring and support related to the
				  individual plan of care to reassess goals and objectives and assess progress
				  and or barriers to progress;
(6)
				  Follow-up contact with the persons served regarding missed appointments
				  (including physician/medication, therapy, rehabilitation, or other supportive
				  service appointments as delineated on the service plan); and
(7) Crisis diversion (unanticipated,
				  unscheduled situation requiring supportive assistance, face-to-face or
				  telephone, to resolve immediate problems before they become overwhelming and
				  severely impair the individual's ability to function or maintain in the
				  community) to prevent progression to a higher level of care.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 1 - CASE MANAGEMENT › Section 450:70-6-2 - Case management services, locale and frequency [REVOKED]

Current through Vol. 41, No. 20, July 1, 2024
Added at 24 Ok Reg 2634, eff 7-12-07 ; Revoked at 30 Ok
						Reg 1451, eff 7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 1 - CASE MANAGEMENT › Section 450:70-6-3 - Case management services, staff credentials [REVOKED]

Current through Vol. 41, No. 20, July 1, 2024
Added at 24 Ok Reg 2634, eff 7-12-07 ; Revoked at 30 Ok
						Reg 1451, eff 7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-4 - Levels of Care

Current through Vol. 41, No. 20, July 1, 2024
(a) OTPs shall
				  document the provision of the following levels of care in policy and procedure,
				  with the exception of medication units, unless that level of service is
				  provided. All facilities shall include the requirements found in Facility
				  Record System. All OTPs certified by ODMHSAS providing any of the following
				  levels of care shall also provide short and long term withdrawal treatment
				  services.
(b) Compliance with
				  70-6-4 may be determined by a review of the following:
(1) Policy and Procedures,
(2) Review of treatment records,
				  and
(3) Any other supporting
				  facility documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-5 - Withdrawal Management

Current through Vol. 41, No. 20, July 1, 2024
(a) Any OTP
				  providing medication assisted recovery services shall provide both short- and
				  long-term withdrawal management as defined in
				  450:70-6-7 and
				  450:70-6-8.
(b) The OTP shall have written policy and
				  procedure defining the protocols developed, implemented, and complied with for
				  withdrawal management. Protocols shall:
(1)
				  Promote successful withdrawal management;
(2) Require that dose reduction occur at a
				  rate well tolerated by the person served;
(3) Require that a variety of ancillary
				  services, such as mutual support groups, be available to the person served
				  through the agency or through referral;
(4) Require that the amount of
				  therapy/rehabilitation services available to the person served be increased
				  prior to discharge; and
(5) Require
				  that a person served be re-admitted to the agency or referred to another agency
				  at the first indication of relapse unless it is an administrative withdrawal
				  process.
(6) There is no minimum
				  time in treatment requirement for persons served receiving buprenorphine when
				  granting take-home privileges.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-5.1 - Withdrawal management - Maintenance to withdrawal management

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall have written policy and
				  procedure stating persons served involved in maintenance management will enter
				  withdrawal treatment:
(1) Only when initiated
				  as administrative withdrawal or when requested by the person served and
				  approved by the OTP medical director; and
(2) When planned and supervised by the
				  medical director or a program physician.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-5.2 - Withdrawal management- Reentering maintenance treatment

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall have written policy and
				  procedure stating that if a person served who is receiving managed withdrawal
				  for reasons other than administrative withdrawal, appears to a staff member to
				  relapse, the person served is permitted to reenter maintenance treatment
				  services, if otherwise eligible;
(b) The OTP shall have written policy and
				  procedure stating that if a person served who has completed managed withdrawal
				  services within the past thirty (30) days appears to a staff member to relapse,
				  the person served may be re-admitted to treatment without physical examination
				  or assessment unless requested by the medical director.
(c) The OTP shall ensure there shall be
				  periodic consideration given to withdrawing from continued opioid treatment
				  services, when appropriate to the progress and goals of the person served.
(1) Consideration for withdrawal from
				  continued medication assisted opioid recovery services shall be discussed at
				  least once annually with the person served.
(2) Such consideration and decisions shall be
				  determined by the person served, medical director, and the program staff as
				  part of an individualized treatment planning process and treatment
				  progress.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-6 - Administrative withdrawal

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall
				  have written policy and procedure stating an infraction of program rules by a
				  person served may result in administrative medical withdrawal from methadone or
				  buprenorphine and termination from treatment services. All persons served will
				  be notified of this policy. The program shall develop specific program
				  requirements to address noncompliance with program rules resulting in
				  termination. The violation or noncompliance with rules shall be limited to;
(1) Threats of violence or actual bodily harm
				  to staff or another person served, including abusive language or
				  behavior;
(2) Disruptive behavior,
				  loitering;
(3) Diversion of
				  methadone, selling, distributing, using, or otherwise "dealing" in any illicit
				  drug or chemical, including positive urine tests for non-prescribed medications
				  and drugs;
(4) Continued unexcused
				  absences from therapy/rehabilitation services and other support services;
(5) Involvement in criminal
				  activities;
(6) Any other serious
				  rule violations; and
(7)
				  Non-payment of fees.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-7 - Short-term managed withdrawal

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall
				  have written policy and procedure regarding short-term managed withdrawal
				  treatment services.
(b) There shall
				  be written policy stating a person served may be admitted to short-term managed
				  withdrawal regardless of age. Persons served under the age of eighteen (18) may
				  be admitted with written parent or guardian approval.
(c) The program physician shall document in
				  the clinical record the reason for admitting the person served to short-term
				  managed withdrawal.
(d) Take-home
				  medication is not allowed during short-term managed withdrawal.
(e) A history of one year or more opioid
				  dependence and an attempt at another form of treatment is not required for
				  admission to short-term managed withdrawal.
(f) No test or analysis is required except
				  for the initial drug screening test, and a tuberculin skin test.
(g) The initial treatment plan and periodic
				  treatment plan evaluation required for persons served in comprehensive
				  maintenance are required for persons served in short-term managed
				  withdrawal.
(h) A primary LBHP,
				  Licensure Candidate or CADC must be assigned by the program to monitor progress
				  toward the goal of short-term withdrawal management and possible drug-free
				  treatment referral.
(i) Methadone
				  is required to be administered daily by the OTP in reducing doses to reach a
				  drug-free state over a period not to exceed thirty (30) days. Buprenorphine
				  shall be administered as determined by the OTP medical director.
(j) All other requirements of comprehensive
				  maintenance treatment apply.
(k)
				  Compliance with
				  450:70-6-7 may be determined by:
(1) A review of policies and
				  procedures,
(2) Treatment
				  records,
(3) Interviews with staff,
				  and
(4) Other facility
				  documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-8 - Long-term managed withdrawal

Current through Vol. 41, No. 20, July 1, 2024
(a) There shall be
				  written policy stating a person served may be admitted to long-term managed
				  withdrawal regardless of age. Written approval from a parent or guardian for a
				  person served under the age of eighteen (18) shall be obtained if required by
				  law. If a minor is eligible to self-consent to treatment pursuant to state law,
				  written approval from a parent or guardian is not required.
(b) Methadone is required to be administered
				  daily in reducing doses to reach a drug-free state over a period not to exceed
				  one hundred and eighty (180) days. Buprenorphine shall be administered as
				  determined by the OTP medical director.
(c) The person served is required to be under
				  observation while ingesting the drug at least six (6) days a week. This is not
				  required for buprenorphine.
(d)
				  Initial and random monthly drug screening tests must be performed on each
				  person served.
(e) Initial service
				  plans and monthly service plan reviews are required.
(f) All other requirements of comprehensive
				  maintenance treatment apply.
(g) A
				  history of one year of opioid dependence and an attempt at another form of
				  treatment is not required for admission to long-term withdrawal
				  management.
(h) Compliance with
				  450:70-6-8 may be determined by:
(1) A review of policies and
				  procedures,
(2) Treatment
				  records,
(3) Interviews with staff,
				  and
(4) Other facility
				  documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-9 - Interim maintenance treatment services

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall
				  have documentation before providing interim maintenance treatment services
				  indicating the written approval of both SAMHSA and ODMHSAS.
(b) The OTP shall have written policy and
				  procedure stating the program sponsor may place an individual who is eligible
				  for admission to comprehensive maintenance services in interim maintenance
				  services if the individual cannot be placed in comprehensive maintenance
				  treatment services within a reasonable geographic distance and within fourteen
				  (14) days of application for admission to comprehensive maintenance treatment
				  services.
(c) The OTP shall
				  identify the maximum length of stay in interim opioid services is one hundred
				  and eighty (180) days.
(d) The OTP
				  shall provide a minimum of two (2) drug screens topersons served in interim
				  maintenance during the one hundred and eighty (180) days of interim
				  services.
(e) The OTP shall have
				  written policies and procedures outlining all criteria for transfer from
				  interim maintenance to comprehensive maintenance services. These transfer
				  criteria shall be in writing and shall include, at a minimum, a preference for
				  pregnant women in admitting persons served to interim maintenance and in
				  transferring persons served from interim maintenance to comprehensive
				  maintenance treatment.
(f) The OTP
				  shall have policy and procedure ensuring interim maintenance services shall be
				  provided in a manner consistent with all applicable Federal and State laws and
				  regulations.
(g) The interim
				  maintenance services program shall meet and/or possess all applicable Federal
				  and State certifications, licensures, laws and regulations.
(h) The OTP shall have written policy and
				  procedure stating all rules and requirements for comprehensive maintenance
				  services apply to interim maintenance services with the exception of:
(1) Opioid agonist medication is required to
				  be administered daily and under observation. Unsupervised or take home dosing
				  is not allowed.
(2) A primary LBHP,
				  Licensure Candidate or CADC does not need to be assigned.
(3) Interim maintenance is limited to one
				  hundred and eighty (80) days in any twelve (12) month period.
(4) By day one hundred and twenty (120), a
				  plan for continuing treatment beyond one hundred and eighty (180) days shall be
				  developed and documented in the clinical record.
(5) Educational, rehabilitative and therapy
				  services are not required. However, information pertaining to locally
				  available, community-based resources for ancillary services shall be made
				  available to persons served in interim maintenance.
(5) An initial treatment plan and periodic
				  updates are not required.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-10 - Medication units

Current through Vol. 41, No. 20, July 1, 2024
(a) Before providing
				  medication assisted opioid use disorder services through a stand-alone
				  medication unit, the program must receive the written approval of both SAMHSA
				  and ODMHSAS, and ODMHSAS certification, OBNDD approval, and national
				  accreditation.
(b) Certification as
				  an OTP will not be required for the maintenance or managed withdrawal of a
				  person served who is admitted to a hospital or long term care facility for the
				  treatment for medical conditions other than opioid addiction and who requires
				  maintenance or withdrawal management during the stay in the hospital or long
				  term care facility.
(c) Medication
				  units shall be in compliance with the following:
(1) Currently licensed by the DEA; and
				  approved by SAMHSA.
(2) Written
				  policy and procedure stating the medical director shall make all
				  recommendations for medication dosages according to best medical practice
				  guidelines and all applicable rules contained in this chapter.
(3) Written policy and procedure stating all
				  female consumers shall have a pregnancy test on admission and at least annually
				  thereafter, unless otherwise indicated.
(4) Written policy and procedure to address
				  the provision of all services in compliance with Federal Drug Administration
				  Guidelines for opioid treatment programs in accordance with 42 CFR, Part
				  8.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-10.1 - Mobile medication units

Current through Vol. 41, No. 20, July 1, 2024
(a) Before providing
				  medication assisted opioid used disorder services through a mobile medication
				  unit, the program must provide notification to SAMHSA, ODMHSAS Provider
				  Certification, OBNDD, and the program's national accreditation entity. The
				  mobile medication unit must have an associated OTP physical location for
				  purposes of ODMHSAS certification.
(b) Mobile medication units shall have the
				  following:
(1) Written policy and procedure
				  stating the medical director shall make all recommendations for medication
				  dosages according to best medical practice guidelines and all applicable rules
				  contained in this Chapter.
(2)
				  Written policy and procedure to address the provision of all services in
				  compliance with Federal Drug Administration Guidelines for opioid treatment
				  programs in accordance with 42 CFR, Part 8.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-11 - Programs using opioid antagonist or long acting opioid agonist

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall have written policy and
				  procedure stating a certified substance abuse facility providing a program
				  using an experimental opioid blockade or a long acting agonist or partial
				  agonist in the treatment of an opioid use disorder shall have documentation of
				  approval by the Federal Drug Administration; and comply with all other federal
				  and state statutes and regulations governing such programs.
(b) The OTP shall have written policy and
				  procedure stating the program shall provide at least two (2) hours of services
				  per day before 8:00 A.M. or after 5:00 P.M. for dispensing and
				  therapy/rehabilitation services .
(c) The OTP shall have written policy and
				  procedure stating that unless otherwise indicated all relevant sections of this
				  chapter apply.
(d) Compliance with
				  70-6-11 may be determined by:
(1) A review of
				  facility policy and procedures, and
(2) Documentation of FDA approval.
(3) Other facility documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-12 - HIV/STD/AIDS education, testing and counseling services

Current through Vol. 41, No. 20, July 1, 2024
(a) Every OTP shall provide or refer for
				  Human Immunodeficiency Virus (HIV), Sexually Transmitted Diseases (STD), and
				  Acquired Immunodeficiency Syndrome (AIDS) education, testing, and counseling
				  services for drug dependent persons in accordance with 43A O.S. § 3-425.1
				  and 42 CFR §
											8.12. Every OTP shall:
(1) Provide or refer for educational sessions
				  regarding HIV/STD/AIDS to persons served and the significant other(s) of
				  persons served;
(2) Provide or
				  refer all drug dependent persons, and their identified significant others, for
				  HIV/STD/AIDS testing and counseling;
(3) Provide counseling on preventing exposure
				  to, and the transmission of, HIV, viral hepatitis, and STDs and either directly
				  provide services and treatments or actively link to treatment each person
				  admitted or readmitted to treatment who has received positive test results for
				  these conditions from initial and/or periodic medical examinations;
(4) Provide documentation of services
				  described in (1) through (3) above, including refusal of these services;
				  and
(5) Maintain all test results
				  in the confidential manner prescribed by applicable state or federal statutes
				  or regulations.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-13 - Treatment Professional [REVOKED]

Current through Vol. 41, No. 20, July 1, 2024
Added at 24 Ok Reg 2634, eff 7-12-07 ; Revoked at 30 Ok
						Reg 1455, eff 7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 2 - LEVELS OF TREATMENT › Section 450:70-6-14 - Co-occurring Disorder Capability [REVOKED]

Current through Vol. 41, No. 20, July 1, 2024
Added at 24 Ok Reg 2634, eff 7-12-07 ; Revoked at 30 Ok
						Reg 1455, eff 7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-15 - Clinical Services

Current through Vol. 41, No. 20, July 1, 2024
(a) Each OTP shall
				  use opioid agonists or partial agonists in conjunction with other treatment
				  services including, but not limited to, individual, family and group therapy;
				  case management; Individual Placement and Support services; peer recovery
				  support services; and other services enhancing positive life style changes in
				  the consumer.
(b) The OTP shall
				  provide adequate and appropriate services to each person served as clinically
				  necessary, including medical services, therapy/rehabilitation services, crisis
				  intervention services, vocational/educational services, and other assessment
				  and treatment services. These services must be available at the primary
				  facility, except where the program sponsor has entered into a formal,
				  documented agreement with a private or public agency, organization,
				  practitioner, or institution to provide these services to individuals enrolled
				  in the OTP. The program sponsor, in any event, must be able to document that
				  these services are fully and reasonably available to all persons
				  served.
(c) Services shall be
				  provided by appropriately credentialed staff in accordance with state
				  requirements, including Chapter 50 and Chapter 53 of this Title. Therapy shall
				  be provided by a program LBHP or Licensure Candidate. Rehabilitation services
				  must be provided by a LBHP, Licensure Candidate, CADC or Certified Case Manager
				  II. Case Management services must be provided by a LBHP, Licensure Candidate,
				  CADC, or Certified Case Manager I or II. Peer recovery support services must be
				  provided by a Certified Peer Recovery Support Specialist. Individual Placement
				  and Support (IPS) services must be provided by a provider trained and
				  credentialed in IPS.
(d) The OTP
				  shall have written policy and procedure stating there will be referral to
				  adequate and reasonably accessible community resources, vocational
				  rehabilitation, education, and employment services for consumers who either
				  request such services or who have been determined through the assessment
				  process to be in need of such services.
(e) The OTP shall have written policy and
				  procedure stating consumers shall attend clinical services as prescribed in the
				  individualized service plan and this Chapter.
(f) Compliance with
				  450:70-6-15 may be determined by:
(1) A review of policies and
				  procedures,
(2) Treatment records,
				  and
(3) Other facility
				  documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-15.1 - Dosing

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall
				  have written policy and procedure stating the medical director shall ensure the
				  daily medication dosage of persons served shall conform with all State and
				  Federal guidelines, best medical practice and this Chapter.
(b) Compliance with
				  450:70-6-15.1 may be determined
				  by:
(1) A review of policies and
				  procedures,
(2) Treatment records,
				  and
(3) Other facility
				  documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-15.2 - Medical Director visits

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall
				  have written policy and procedure stating each person served accepted for
				  treatment at an OTP shall be assessed no less than annually by the medical
				  director or an appropriately trained program physician as part of a process to
				  determine the most appropriate combination of services and treatment.
(b) Compliance with
				  450:70-6-15.2 may be determined
				  by:
(1) A review of policies and
				  procedures,
(2) Treatment records,
				  and
(3) Other facility
				  documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-15.3

Current through Vol. 41, No. 20, July 1, 2024
Added at 30 Ok Reg 1456, eff
						7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-15.4 - Termination of treatment

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall
				  have written policy and procedure stating if a person served misses
				  appointments for two weeks or more without notifying the clinic, the episode of
				  care is considered terminated and is to be so noted in the clinical record. An
				  exception determination would be in circumstances where the person served can
				  provide documented proof of exceptional circumstances. The documentation must
				  be maintained in the clinical record. If the person served does return for care
				  and is accepted into the program, the person served is considered a new person
				  served and is to be so noted in the clinical record.
(b) Compliance with
				  450:70-6-15.4 may be determined
				  by:
(1) A review of policies and
				  procedures,
(2) Treatment records,
				  and
(3) Other facility
				  documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-16 - Treatment for persons served who are pregnant

Current through Vol. 41, No. 20, July 1, 2024
(a) The
				  OTP shall have written policy and procedure stating the OTP address the special
				  needs of persons served who are pregnant. Prenatal care for persons served who
				  are pregnant must be provided either by the OTP or by referral to appropriate
				  healthcare providers.
(b) An OTP
				  shall ensure that policies and procedures are developed, implemented, and
				  complied with for the treatment of persons served who are pregnant, to include:
(1) Documentation that staff members are
				  educated in the unique needs ofpersons served who are pregnant;
(2) Priority for pregnant individuals seeking
				  medication assisted opioid treatment medications for opioid use
				  disorder;
(3) Documentation of the
				  reasons for a pregnant individual's denial of admission to an agency;
(4) Availability of prenatal care for persons
				  served who are pregnant either at the agency or through referral to a medical
				  practitioner;
(5) Written
				  agreement(s) with a medical practitioner who is providing prenatal care to a
				  person served who is pregnant, to include procedures for exchanging medication
				  assisted opioid treatment and prenatal care information regarding medications
				  utilized for opioid use disorder and prenatal care;
(6) Education from agency staff to a person
				  served who is pregnant who does not obtain prenatal care services for prenatal
				  care;
(7) Procedures to obtain a
				  written refusal of prenatal care services from a person served who is pregnant
				  who refuses prenatal care services offered by the agency or a referral for
				  prenatal care;
(8) Procedures to
				  ensure a person served who is pregnant receiving comprehensive maintenance
				  treatment before pregnancy shall be maintained at the pre-pregnancy dose of
				  opioid agonist or partial agonist medication, if effective;
(9) Monitoring by an agency medical
				  practitioner of a person served who is pregnant to determine if pregnancy
				  induced changes in the elimination or metabolization of opioid agonist or
				  partial agonist treatment medication may necessitate an increased or split
				  dose; and
(10) Referral of a person
				  served who is pregnant who is discharged from the agency to a medical
				  practitioner and that a staff member document the name, address, and telephone
				  number of the medical practitioner in the clinical record.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-17

Current through Vol. 41, No. 20, July 1, 2024
Added at 24 Ok Reg 2634, eff 7-12-07 ; Amended at 26 Ok
						Reg 1303, eff 7-1-09 ; Amended at 30 Ok Reg 1457, eff
						7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-17.1

Current through Vol. 41, No. 20, July 1, 2024
Added at 30 Ok Reg 1459, eff
						7-1-13
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-17.2 - Service phases - General

Current through Vol. 41, No. 20, July 1, 2024
(a) The OTP shall
				  have written policy and procedure describing structured phases of treatment and
				  rehabilitation to support progress of persons served and to establish
				  requirements regarding attendance and service participation. The requirements
				  listed below for each phase indicate minimum requirements and the frequency and
				  extent of treatment and rehabilitation services may be increased, based on
				  individual patient need and unless otherwise indicated in this chapter. The OTP
				  shall utilize ASAM criteria to determine the appropriate level of care during
				  each phase of treatment.
(b) If an
				  OTP is providing doses to a person served receiving residential level of care
				  substance use disorder services, the required minimum services listed for each
				  phase may be delivered by the residential level of care substance use disorder
				  provider. The OTP shall document the provision of these services and the
				  provider delivering such services in the service plan.
(c) Compliance with
				  450:70-6-17.2 may be determined
				  by:
(1) A review of policies and
				  procedures,
(2) Treatment records,
				  and
(3) Other facility
				  documentation.
Oklahoma Administrative Code › Title 450 - Department of Mental Health and Substance Abuse Services › Chapter 70 - Standards and Criteria for Opioid Treatment Programs › Subchapter 6 - Substance Use Disorder Treatment Services › Part 3 - TREATMENT SERVICES › Section 450:70-6-17.3 - Service phases - Phase I

Current through Vol. 41, No. 20, July 1, 2024
(a) Phase I consists
				  of the first ninety (90) days of treatment. During Phase I, a minimum of four
				  (4) treatment sessions per month shall be provided. Available services shall
				  include, but not be limited to, therapy, rehabilitation, case management,
				  Individual Placement and Support services, and peer recovery support
				  services.
(b) Compliance with
				  450:70-6-17.3 may be determined
				  by:
(1) A review of policies and
				  procedures,
(2) Treatment records,
				  and
(3) Other facility
				  documentation.